Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 521

1.

Extensive nitrification and active ammonia oxidizers in two contrasting coastal systems of the Baltic Sea.

Happel E, Bartl I, Voss M, Riemann L.

Environ Microbiol. 2018 Jun 19. doi: 10.1111/1462-2920.14293. [Epub ahead of print]

PMID:
29921003
2.

WHITE MATTER CORRELATES OF DIFFERENT ASPECTS OF FACIAL AFFECT RECOGNITION IMPAIRMENT FOLLOWING TRAUMATIC BRAIN INJURY.

Rigon A, Voss MW, Turkstra LS, Mutlu B, Duff MC.

Soc Neurosci. 2018 Jun 14. doi: 10.1080/17470919.2018.1489302. [Epub ahead of print]

PMID:
29902960
3.

Decision-making in schizophrenia: A predictive-coding perspective.

Sterzer P, Voss M, Schlagenhauf F, Heinz A.

Neuroimage. 2018 May 31. pii: S1053-8119(18)30500-7. doi: 10.1016/j.neuroimage.2018.05.074. [Epub ahead of print] Review.

PMID:
29860087
4.

Commercial quality "awards" are not a strong indicator of quality surgical care.

Cobb AN, Erickson TR, Kothari AN, Eguia E, Brownlee SA, Yao W, Choi H, Greenberg V, Mboya J, Voss M, Raicu DS, Settimi-Woods R, Kuo PC.

Surgery. 2018 May 22. pii: S0039-6060(18)30159-4. doi: 10.1016/j.surg.2018.04.010. [Epub ahead of print]

PMID:
29801732
5.

β-Phenylalanine Ester Synthesis from Stable β-Keto Ester Substrate Using Engineered ω-Transaminases.

Buß O, Voss M, Delavault A, Gorenflo P, Syldatk C, Bornscheuer U, Rudat J.

Molecules. 2018 May 18;23(5). pii: E1211. doi: 10.3390/molecules23051211.

6.

Doxycycline Impairs Mitochondrial Function and Protects Human Glioma Cells from Hypoxia-Induced Cell Death: Implications of Using Tet-Inducible Systems.

Luger AL, Sauer B, Lorenz NI, Engel AL, Braun Y, Voss M, Harter PN, Steinbach JP, Ronellenfitsch MW.

Int J Mol Sci. 2018 May 17;19(5). pii: E1504. doi: 10.3390/ijms19051504.

7.

Functional neural correlates of facial affect recognition impairment following TBI.

Rigon A, Voss MW, Turkstra LS, Mutlu B, Duff MC.

Brain Imaging Behav. 2018 May 8. doi: 10.1007/s11682-018-9889-x. [Epub ahead of print]

PMID:
29737489
8.

Randomized control trial of computer-based training targeting alertness in older adults: the ALERT trial protocol.

VanVleet T, Voss M, Dabit S, Mitko A, DeGutis J.

BMC Psychol. 2018 May 3;6(1):22. doi: 10.1186/s40359-018-0233-4.

9.

Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer.

Hellmann MD, Nathanson T, Rizvi H, Creelan BC, Sanchez-Vega F, Ahuja A, Ni A, Novik JB, Mangarin LMB, Abu-Akeel M, Liu C, Sauter JL, Rekhtman N, Chang E, Callahan MK, Chaft JE, Voss MH, Tenet M, Li XM, Covello K, Renninger A, Vitazka P, Geese WJ, Borghaei H, Rudin CM, Antonia SJ, Swanton C, Hammerbacher J, Merghoub T, McGranahan N, Snyder A, Wolchok JD.

Cancer Cell. 2018 May 14;33(5):843-852.e4. doi: 10.1016/j.ccell.2018.03.018. Epub 2018 Apr 12.

10.

Polio transition: overlooked challenges.

Razum O, Voss M.

Lancet. 2018 Apr 7;391(10128):1353-1354. doi: 10.1016/S0140-6736(18)30503-8. No abstract available.

PMID:
29636267
12.

Different aspects of facial affect recognition impairment following traumatic brain injury: The role of perceptual and interpretative abilities.

Rigon A, Voss MW, Turkstra LS, Mutlu B, Duff MC.

J Clin Exp Neuropsychol. 2018 Mar 22:1-15. doi: 10.1080/13803395.2018.1437120. [Epub ahead of print]

PMID:
29562838
13.

Discovery of a highly potent orally bioavailable imidazo-[1, 2-a]pyrazine Aurora inhibitor.

Yu T, Zhang Y, Kerekes AD, Tagat JR, Doll RJ, Xiao Y, Esposite S, Hruza A, Belanger DB, Voss M, Rainka MP, Basso A, Liu M, Liang L, Sui N, Prelusky D, Rindgen D, Zhang L.

Bioorg Med Chem Lett. 2018 May 1;28(8):1397-1403. doi: 10.1016/j.bmcl.2018.02.037. Epub 2018 Feb 23.

PMID:
29545102
14.

A RAB27A 5' untranslated region structural variant associated with late-onset hemophagocytic lymphohistiocytosis and normal pigmentation.

Tesi B, Rascon J, Chiang SCC, Burnyte B, Löfstedt A, Fasth A, Heizmann M, Juozapaite S, Kiudeliene R, Kvedaraite E, Miseviciene V, Muleviciene A, Müller ML, Nordenskjöld M, Matuzeviciene R, Samaitiene R, Speckmann C, Stankeviciene S, Zekas V, Voss M, Ehl S, Vaiciene-Magistris N, Henter JI, Meeths M, Bryceson YT.

J Allergy Clin Immunol. 2018 Mar 6. pii: S0091-6749(18)30323-3. doi: 10.1016/j.jaci.2018.02.031. [Epub ahead of print] No abstract available.

15.

Age differences in episodic associative learning.

Clark R, Hazeltine E, Freedberg M, Voss MW.

Psychol Aging. 2018 Feb;33(1):144-157. doi: 10.1037/pag0000234.

PMID:
29494185
16.

Functional neural correlates of slower gait among older adults with mild cognitive impairment.

Hsu CL, Best JR, Voss MW, Handy TC, Beauchet O, Lim C, Liu-Ambrose T.

J Gerontol A Biol Sci Med Sci. 2018 Feb 17. doi: 10.1093/gerona/gly027. [Epub ahead of print]

PMID:
29471385
17.

The next step forward?

Kickbusch I, Franz C, Voss M.

BMJ. 2018 Feb 20;360:k788. doi: 10.1136/bmj.k788. No abstract available.

PMID:
29463501
18.

Genomic Classifiers in Renal Cell Carcinoma.

Hakimi AA, Voss MH.

Eur Urol. 2018 May;73(5):770-771. doi: 10.1016/j.eururo.2018.01.013. Epub 2018 Feb 1. No abstract available.

PMID:
29395501
19.
20.

New MR perfusion features in primary central nervous system lymphomas: pattern and prognostic impact.

Blasel S, Vorwerk R, Kiyose M, Mittelbronn M, Brunnberg U, Ackermann H, Voss M, Harter PN, Hattingen E.

J Neurol. 2018 Mar;265(3):647-658. doi: 10.1007/s00415-018-8737-7. Epub 2018 Jan 30.

PMID:
29383512
21.

Role of DDX3 in the pathogenesis of inflammatory bowel disease.

Tantravedi S, Vesuna F, Winnard PT Jr, Van Voss MRH, Van Diest PJ, Raman V.

Oncotarget. 2017 Dec 15;8(70):115280-115289. doi: 10.18632/oncotarget.23323. eCollection 2017 Dec 29.

22.

Scholastic performance and functional connectivity of brain networks in children.

Chaddock-Heyman L, Weng TB, Kienzler C, Erickson KI, Voss MW, Drollette ES, Raine LB, Kao SC, Hillman CH, Kramer AF.

PLoS One. 2018 Jan 24;13(1):e0190073. doi: 10.1371/journal.pone.0190073. eCollection 2018.

23.

Brain Network Modularity Predicts Exercise-Related Executive Function Gains in Older Adults.

Baniqued PL, Gallen CL, Voss MW, Burzynska AZ, Wong CN, Cooke GE, Duffy K, Fanning J, Ehlers DK, Salerno EA, Aguiñaga S, McAuley E, Kramer AF, D'Esposito M.

Front Aging Neurosci. 2018 Jan 4;9:426. doi: 10.3389/fnagi.2017.00426. eCollection 2017.

24.
25.

Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma.

Miao D, Margolis CA, Gao W, Voss MH, Li W, Martini DJ, Norton C, Bossé D, Wankowicz SM, Cullen D, Horak C, Wind-Rotolo M, Tracy A, Giannakis M, Hodi FS, Drake CG, Ball MW, Allaf ME, Snyder A, Hellmann MD, Ho T, Motzer RJ, Signoretti S, Kaelin WG Jr, Choueiri TK, Van Allen EM.

Science. 2018 Feb 16;359(6377):801-806. doi: 10.1126/science.aan5951. Epub 2018 Jan 4.

PMID:
29301960
26.

Optimizing Treatment Approaches in Advanced Renal Cancer.

Osorio JC, Motzer RJ, Voss MH.

Oncology (Williston Park). 2017 Dec 15;31(12):919-26, 928-30. Review.

27.

The Relationship of PROMIS Pain Interference and Physical Function Scales.

Kendall R, Wagner B, Brodke D, Bounsanga J, Voss M, Gu Y, Spiker R, Lawrence B, Hung M.

Pain Med. 2017 Dec 7. doi: 10.1093/pm/pnx310. [Epub ahead of print]

PMID:
29228284
28.

Striking a chord with healthy aging: memory system cooperation is related to preserved configural response learning in older adults.

Voss MW, Clark R, Freedberg M, Weng T, Hazeltine E.

Neurobiol Aging. 2018 Mar;63:44-53. doi: 10.1016/j.neurobiolaging.2017.11.001. Epub 2017 Nov 14.

PMID:
29223679
29.

Constitutional SAMD9L mutations cause familial myelodysplastic syndrome and transient monosomy 7.

Pastor VB, Sahoo SS, Boklan J, Schwabe GC, Saribeyoglu E, Strahm B, Lebrecht D, Voss M, Bryceson YT, Erlacher M, Ehninger G, Niewisch M, Schlegelberger B, Baumann I, Achermann JC, Shimamura A, Hochrein J, Tedgård U, Nilsson L, Hasle H, Boerries M, Busch H, Niemeyer CM, Wlodarski MW.

Haematologica. 2018 Mar;103(3):427-437. doi: 10.3324/haematol.2017.180778. Epub 2017 Dec 7.

30.

[Education and Training in Public Health - Results of the Working Group 9 of the Forum Future Public Health, Berlin 2016].

Dragano N, Geffert K, Geisel B, Hartmann T, Hoffmann F, Schneider S, Voss M, Gerhardus A.

Gesundheitswesen. 2017 Nov;79(11):929-931. doi: 10.1055/s-0043-119358. Epub 2017 Nov 24. German.

PMID:
29172221
31.

Characterizing recurrent and lethal small renal masses in clear cell renal cell carcinoma using recurrent somatic mutations.

Manley BJ, Reznik E, Ghanaat M, Kashan M, Becerra MF, Casuscelli J, Tennenbaum D, Redzematovic A, Carlo MI, Sato Y, Arcila M, Voss MH, Feldman DR, Motzer RJ, Russo P, Coleman J, Hsieh JJ, Hakimi AA.

Urol Oncol. 2017 Nov 10. pii: S1078-1439(17)30549-5. doi: 10.1016/j.urolonc.2017.10.012. [Epub ahead of print]

PMID:
29132830
32.

Comparative Genomic Profiling of Matched Primary and Metastatic Tumors in Renal Cell Carcinoma.

Becerra MF, Reznik E, Redzematovic A, Tennenbaum DM, Kashan M, Ghanaat M, Casuscelli J, Manley B, Jonsson P, DiNatale RG, Blum KA, Durack JC, Solomon SB, Arcila ME, Bourque C, Socci N, Carlo MI, Lee CH, Voss MH, Feldman DR, Motzer RJ, Coleman JA, Russo P, Cheng EH, Hakimi AA, Hsieh JJ.

Eur Urol Focus. 2017 Oct 20. pii: S2405-4569(17)30237-7. doi: 10.1016/j.euf.2017.09.016. [Epub ahead of print]

PMID:
29066084
33.

Gender Identity and Malnutrition: So Much Remains Unknown.

Moser C, Voss M, Jansen-Kraly K, Jacobson J.

J Adolesc Health. 2017 Nov;61(5):661-662. doi: 10.1016/j.jadohealth.2017.07.023. No abstract available.

PMID:
29061233
34.

Dabrafenib in patients with recurrent, BRAF V600E mutated malignant glioma and leptomeningeal disease.

Burger MC, Ronellenfitsch MW, Lorenz NI, Wagner M, Voss M, Capper D, Tzaridis T, Herrlinger U, Steinbach JP, Stoffels G, Langen KJ, Brandts C, Senft C, Harter PN, Bähr O.

Oncol Rep. 2017 Dec;38(6):3291-3296. doi: 10.3892/or.2017.6013. Epub 2017 Oct 2.

35.

Characterization and Impact of TERT Promoter Region Mutations on Clinical Outcome in Renal Cell Carcinoma.

Casuscelli J, Becerra MF, Manley BJ, Zabor EC, Reznik E, Redzematovic A, Arcila ME, Tennenbaum DM, Ghanaat M, Kashan M, Stief CG, Carlo M, Voss MH, Feldman DR, Motzer RJ, Chen Y, Reuter VE, Coleman JA, Russo P, Hsieh JJ, Hakimi AA.

Eur Urol Focus. 2017 Sep 23. pii: S2405-4569(17)30212-2. doi: 10.1016/j.euf.2017.09.008. [Epub ahead of print]

PMID:
28951115
36.

A randomized phase II trial of CRLX101 in combination with bevacizumab versus standard of care in patients with advanced renal cell carcinoma.

Voss MH, Hussain A, Vogelzang N, Lee JL, Keam B, Rha SY, Vaishampayan U, Harris WB, Richey S, Randall JM, Shaffer D, Cohn A, Crowell T, Li J, Senderowicz A, Stone E, Figlin R, Motzer RJ, Haas NB, Hutson T.

Ann Oncol. 2017 Nov 1;28(11):2754-2760. doi: 10.1093/annonc/mdx493.

PMID:
28950297
37.

Profiling Arthritis Pain with a Decision Tree.

Hung M, Bounsanga J, Liu F, Voss MW.

Pain Pract. 2018 Jun;18(5):568-579. doi: 10.1111/papr.12645. Epub 2017 Nov 20.

PMID:
28949092
38.

Interpretation of correlations in clinical research.

Hung M, Bounsanga J, Voss MW.

Postgrad Med. 2017 Nov;129(8):902-906. doi: 10.1080/00325481.2017.1383820. Epub 2017 Sep 27. Review.

PMID:
28936887
39.

Evaluating instrument responsiveness in joint function: The HOOS JR, the KOOS JR, and the PROMIS PF CAT.

Hung M, Saltzman CL, Greene T, Voss MW, Bounsanga J, Gu Y, Anderson MB, Peters CL, Gililland J, Pelt CE.

J Orthop Res. 2018 Apr;36(4):1178-1184. doi: 10.1002/jor.23739. Epub 2017 Oct 9.

PMID:
28921658
40.

Corrigendum: The Impact of Aerobic Exercise on Fronto-Parietal Network Connectivity and Its Relation to Mobility: An Exploratory Analysis of a 6-Month Randomized Controlled Trial.

Hsu CL, Best JR, Wang S, Voss MW, Hsiung RGY, Munkacsy M, Cheung W, Handy TC, Liu-Ambrose T.

Front Hum Neurosci. 2017 Sep 5;11:449. doi: 10.3389/fnhum.2017.00449. eCollection 2017.

41.

In and out of control: brain mechanisms linking fluency of action selection to self-agency in patients with schizophrenia.

Voss M, Chambon V, Wenke D, Kühn S, Haggard P.

Brain. 2017 Aug 1;140(8):2226-2239. doi: 10.1093/brain/awx136.

PMID:
28899009
42.

OncoKB: A Precision Oncology Knowledge Base.

Chakravarty D, Gao J, Phillips SM, Kundra R, Zhang H, Wang J, Rudolph JE, Yaeger R, Soumerai T, Nissan MH, Chang MT, Chandarlapaty S, Traina TA, Paik PK, Ho AL, Hantash FM, Grupe A, Baxi SS, Callahan MK, Snyder A, Chi P, Danila D, Gounder M, Harding JJ, Hellmann MD, Iyer G, Janjigian Y, Kaley T, Levine DA, Lowery M, Omuro A, Postow MA, Rathkopf D, Shoushtari AN, Shukla N, Voss M, Paraiso E, Zehir A, Berger MF, Taylor BS, Saltz LB, Riely GJ, Ladanyi M, Hyman DM, Baselga J, Sabbatini P, Solit DB, Schultz N.

JCO Precis Oncol. 2017 Jul;2017. doi: 10.1200/PO.17.00011. Epub 2017 May 16.

PMID:
28890946
43.

Trajectories and characteristics of work disability before and after acute myocardial infarction.

Wang M, Vaez M, Dorner TE, Tiihonen J, Voss M, Ivert T, Mittendorfer-Rutz E.

Heart. 2018 Feb;104(4):340-348. doi: 10.1136/heartjnl-2017-311950. Epub 2017 Sep 1.

PMID:
28864716
44.

Tumor Xenografts of Human Clear Cell Renal Cell Carcinoma But Not Corresponding Cell Lines Recapitulate Clinical Response to Sunitinib: Feasibility of Using Biopsy Samples.

Dong Y, Manley BJ, Becerra MF, Redzematovic A, Casuscelli J, Tennenbaum DM, Reznik E, Han S, Benfante N, Chen YB, Arcila ME, Aras O, Voss MH, Feldman DR, Motzer RJ, Fabbri N, Healey JH, Boland PJ, Chawla M, Durack JC, Lee CH, Coleman JA, Russo P, Hakimi AA, Cheng EH, Hsieh JJ.

Eur Urol Focus. 2017 Dec;3(6):590-598. doi: 10.1016/j.euf.2016.08.005. Epub 2016 Aug 25.

PMID:
28753786
45.

Integration of Recurrent Somatic Mutations with Clinical Outcomes: A Pooled Analysis of 1049 Patients with Clear Cell Renal Cell Carcinoma.

Manley BJ, Zabor EC, Casuscelli J, Tennenbaum DM, Redzematovic A, Becerra MF, Benfante N, Sato Y, Morikawa T, Kume H, Fukayama M, Homma Y, Ogawa S, Arcila ME, Voss MH, Feldman DR, Coleman JA, Reuter VE, Motzer RJ, Russo P, Hsieh JJ, Hakimi AA.

Eur Urol Focus. 2017 Oct;3(4-5):421-427. doi: 10.1016/j.euf.2016.06.015. Epub 2016 Jul 16.

PMID:
28753773
46.

Characterization of Enterococcus faecalis isolates by chicken embryo lethality assay and ERIC-PCR.

Blanco AE, Barz M, Cavero D, Icken W, Sharifi AR, Voss M, Buxadé C, Preisinger R.

Avian Pathol. 2018 Feb;47(1):23-32. doi: 10.1080/03079457.2017.1359404. Epub 2017 Aug 31.

PMID:
28737107
47.

The Impact of Aerobic Exercise on Fronto-Parietal Network Connectivity and Its Relation to Mobility: An Exploratory Analysis of a 6-Month Randomized Controlled Trial.

Hsu CL, Best JR, Wang S, Voss MW, Hsiung RGY, Munkacsy M, Cheung W, Handy TC, Liu-Ambrose T.

Front Hum Neurosci. 2017 Jun 30;11:344. doi: 10.3389/fnhum.2017.00344. eCollection 2017. Erratum in: Front Hum Neurosci. 2017 Sep 05;11:449.

48.

Bevacizumab as a last-line treatment for glioblastoma following failure of radiotherapy, temozolomide and lomustine.

Wenger KJ, Wagner M, You SJ, Franz K, Harter PN, Burger MC, Voss M, Ronellenfitsch MW, Fokas E, Steinbach JP, Bähr O.

Oncol Lett. 2017 Jul;14(1):1141-1146. doi: 10.3892/ol.2017.6251. Epub 2017 May 25.

49.

Safety and Efficacy of Nivolumab in Combination With Ipilimumab in Metastatic Renal Cell Carcinoma: The CheckMate 016 Study.

Hammers HJ, Plimack ER, Infante JR, Rini BI, McDermott DF, Lewis LD, Voss MH, Sharma P, Pal SK, Razak ARA, Kollmannsberger C, Heng DYC, Spratlin J, McHenry MB, Amin A.

J Clin Oncol. 2017 Dec 1;35(34):3851-3858. doi: 10.1200/JCO.2016.72.1985. Epub 2017 Jul 5.

PMID:
28678668
50.

Genomic Characterization of Renal Medullary Carcinoma and Treatment Outcomes.

Carlo MI, Chaim J, Patil S, Kemel Y, Schram AM, Woo K, Coskey D, Nanjangud GJ, Voss MH, Feldman DR, Hsieh JJ, Hakimi AA, Chen YB, Motzer RJ, Lee CH.

Clin Genitourin Cancer. 2017 Dec;15(6):e987-e994. doi: 10.1016/j.clgc.2017.04.012. Epub 2017 Apr 26.

PMID:
28558987

Supplemental Content

Support Center